Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysis. Issue 1 (4th June 2022)

Record Type:: Journal Article
Title:: Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysis. Issue 1 (4th June 2022)
Main Title:: Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysis
Authors:: Dimopoulos, Meletios A.
Moreau, Philippe
Augustson, Bradley
Castro, Nelson
Pika, Tomas
Delimpasi, Sosana
De la Rubia, Javier
Maiolino, Angelo
Reiman, Tony
Martinez‐Lopez, Joaquin
Martin, Thomas
Mikhael, Joseph
Yong, Kwee
Risse, Marie‐Laure
Asset, Gaelle
Marion, Sylvia
Hajek, Roman
Abstract:
Is Part Of:: American journal of hematology. Volume 98:Issue 1(2023)
Journal:: American journal of hematology
Issue:: Volume 98:Issue 1(2023)
Issue Display:: Volume 98, Issue 1 (2023)
Year:: 2023
Volume:: 98
Issue:: 1
Issue Sort Value:: 2023-0098-0001-0000
Page Start:: E15
Page End:: E19
Publication Date:: 2022-06-04
Subjects:: Hematology -- Periodicals
616.15
Journal URLs:: http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1096-8652 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1002/ajh.26602 ↗
Languages:: English
ISSNs:: 0361-8609
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 0824.800000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 24723.xml